THERAtRAME
1 known investors
THERAtRAME is a biotech company developing cancer therapies that target tRNA modifications, a layer of gene regulation linked to tumor adaptability and resistance. Its work focuses on immune-refractory and targeted-therapy-resistant tumors, aiming to advance a lead program into clinical development.
AI & Machine LearningBiotech
Investors · 1
Frequently asked questions
- What does THERAtRAME do?
- THERAtRAME is a biotech company developing cancer therapies that target tRNA modifications, a layer of gene regulation linked to tumor adaptability and resistance. Its work focuses on immune-refractory and targeted-therapy-resistant tumors, aiming to advance a lead program into clinical development.
- Who are THERAtRAME's investors?
- THERAtRAME's investors include Qbic Fund.